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Paracellular and transcellular migration of metastatic cells 































































and	 in	vivo.	Our	 results	 indicate	 that	breast	 cancer	cells	 are	more	effective	 in	 the	
transcellular	type	of	migration	than	melanoma	cells.



























mechanisms	 involved.	 Development	 of	metastases	 of	 the	 CNS	 de-
pends	on	the	unique	interaction	between	tumour	cells	and	cells	of	the	
neurovascular	unit	 (NVU).11	 It	has	been	suggested	that	both	blood-	













Transendothelial	 migration	 of	 tumour	 cells	 might	 involve	 dis-
ruption	of	 the	TJs	and	consequently	the	paracellular	movement	of	
the	 tumour	 cells.	We	 have	 previously	 demonstrated	 the	 ability	 of	
melanoma	cells	to	breach	the	junctional	complex	of	cerebral	endo-
thelial	cells	 (CECs)	 through	direct	contact	and	secretion	of	soluble	







to	an	 increase	 in	 the	ability	of	melanoma	cells	 to	attach	 to	and	 to	
migrate	through	CECs.18
Besides	 the	 paracellular	 route,	 brain-	invading	 cells	 might	 also	
take	the	transcellular	way,	through	individual	endothelial	cells.	Our	















Waltham,	MA,	USA).	 B16/F10	murine	melanoma	 cells	were	 kept	 in	
Roswell	Park	Memorial	 Institute	 (RPMI)	1640	medium	(Pan	Biotech,	
Aidenbach,	Germany)	supplemented	with	5%	FBS	(PAA	Laboratories)	












tometer.	For	 further	 selection,	 tdTomato-	4T1	cells	were	cultured	 in	
G418-	containing	medium.	EmGFP	(emerald	GFP)-	expressing	4T1	cells	
were	 prepared	 by	 retroviral	 transfection,	 as	 described	 elsewhere19 
and	selected	on	blasticidin	S	(Sigma	Aldrich).	The	hCMEC/D3	human	
cerebral	 endothelial	 microvascular	 cells	 (abbreviated	 D3;	 obtained	
from	 Pierre-	Olivier	 Couraud,	 Institut	 Cochin,	 Paris,	 France)	 were	
grown	on	 rat	 tail	 collagen-	coated	dishes	 in	Endothelial	Cell	Growth	
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gation	 in	20%	BSA,	 a	 second	digestion	was	performed	using	1	mg/mL	 























Venus-	YFP	 (yellow	 fluorescent	 protein)	 in	 endothelial	 cells.	 These	
animals	 were	 inoculated	 with	 tdTomato-	4T1	 cells.	 All	 mice	 were	
housed	and	treated	 in	accordance	with	widely	accepted	standards	
and	the	protocols	were	approved	by	the	 institutional	care	and	the	
Regional	 Animal	 Health	 and	 Food	 Control	 Station	 of	 Csongrád	
County	(permit	numbers:	XVI./2980/2012	and	XVI./764/2018).
Animals	were	injected	with	100	μL	Ringer-	Hepes	buffer	contain-










were	 prepared	 using	 a	 Leica	 VT1000	 S	 vibratome.	 Sections	were	
examined	 under	 a	 fluorescence	 microscope.	 Sections	 containing	
EmGFP-	4T1	cells	were	further	used.
The	 filter	 inserts	 or	 the	 selected	 brain	 slices	 were	 fixed	 for	
2.5	hours	 in	2.7%	glutaraldehyde	 and	post-	fixed	 for	75	minutes	 in	










in	PBS	 at	 room	 temperature	 and	blocked	with	 3%	bovine	 serum	al-













cryosections	 were	 prepared	 and	 used	 for	 immunofluorescence.	
Brain	 sections	 were	 placed	 in	 plates	 and	 subjected	 to	 antigen	
retrieval	using	100%	methanol	 for	30	minutes.	Permeabilization	
was	 performed	 with	 0.5%	 TritonX-	100	 for	 30	minutes	 at	 room	
temperature,	followed	by	blocking	with	3%	BSA	in	PBS.	The	first	
antibody	was	applied	in	a	dilution	of	1:100	in	1%	BSA	overnight	
at	 4°C.	 After	 washing	 in	 PBS,	 the	 secondary	 antibody	 (STAR	
RED	anti-	mouse	IgG;	Abberior,	Göttingen,	Germany)	was	applied	
in	 a	 dilution	 of	 1:500	 in	 PBS	 for	 1	hour	 at	 room	 temperature.	
After	 three	 further	washing	 steps,	 samples	were	mounted	with	





EGFP-	MDA-	MB-	231	 cells	 were	 co-	cultured	 with	 D3	 cells	 for	
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Santa	 Cruz,	 CA,	 USA).	 Laemmli	 buffer	 was	 added	 to	 the	 samples	
followed	by	heating	on	95°C	 for	3	minutes.	 Proteins	were	 electro-
phoresed	using	standard	denaturing	SDS-	PAGE	procedures	and	blot-




were	 incubated	with	primary	antibodies	 in	TBS-	T	using	 the	 follow-
ing	dilutions:	1:200	cofilin	(Cell	Signaling	Technology,	Danvers,	MA,	
USA),	 1:200	 phospho-	cofilin	 (Cell	 Signaling	 Technology),	 1:1000	
β-	actin	 (Sigma	 Aldrich),	 1:500	 pan-	cytokeratin	 (Thermo	 Fischer	
Scientific),	 1:250	 claudin-	5	 (Thermo	 Fischer	 Scientific)	 or	 1:200	N-	
cadherin	(BD	Transduction	Laboratories).	Blots	were	washed	in	TBS-	T	
and	 incubated	with	 the	 secondary	 antibodies	 in	 TBS-	T,	 as	 follows:	
HRP-	conjugated	anti-	rabbit	IgG	(1:1000,	Cell	Signalling	Technology)	
or	 HRP-	conjugated	 anti-	mouse	 IgG	 (1:4000,	 BD	 Transduction	





To	 monitor	 the	 effects	 of	 tumour	 cells	 on	 RBECs	 in	 real	 time,	
we	 measured	 the	 electrical	 impedance	 using	 the	 xCELLi-
gence	 system	 following	 the	 manufacturer's	 instructions	 (Acea	
Biosciences).	Briefly,	 cells	were	seeded	 in	an	E-	plate	 (ie,	96-	well	
tissue	 culture	 plates	 having	 micro-	electrodes	 integrated	 on	 the	
bottom)	 and	 allowed	 to	 attach	 onto	 the	 electrode	 surface	 over	
time.	 The	 electrical	 impedance	was	 recorded	 every	 30	minutes.	
When	the	impedance	reached	plateau	(ie	the	monolayer	reached	
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hydrocortisone,	 250	μmol	 L−1	 CPT-	cAMP	 and	 17.5	μmol	 L−1	 RO-	
201724	(Sigma	Aldrich)	to	induce	maturation	of	TJs.	Tumour	cells	














Since	 our	 previous	 results	 indicated	 that	melanoma	 cells	 have	 in-
creased	ability	to	attach	to	and	to	migrate	through	brain	endothelial	
cells	 than	 breast	 cancer	 cells,	we	 aimed	 to	 investigate	 these	 phe-
nomena	at	ultrastructural	level.
We	 first	 focused	on	 the	 adhesion	 step,	which	 precedes	 trans-
migration	 of	 tumour	 cells	 through	 endothelial	 cells.	We	 observed	
several	melanoma	cells	attached	 to	brain	endothelial	 cells	 in	close	
proximity	 to	 the	 interendothelial	 junctions	 (Figure	1A),	 but	 also	 in	
regions	 distant	 from	 endothelial-	endothelial	 contacts	 (Figure	1B).	
Brain	 endothelial	 cells	 extended	 filopodia-	like	 membrane	 pro-
trusions	 towards	 melanoma	 cells	 (Figure	1B),	 probably	 having	 an	
important	role	in	the	intercalation	of	the	tumour	cell	between	endo-
thelial	cells	(Figure	1C).
As	 a	 result,	 melanoma	 cells	 transmigrated	 paracellularly,	
through	the	tight	and	adherens	junctions	between	endothelial	cells	
(Figure	2A	and	B).	Some	melanoma	cells	attached	in	clusters	to	the	
brain	 endothelial	 monolayer	 (Figure	2A)	 facilitating	 utilization	 of	
the	same	transmigration	path	by	more	cells,	as	we	have	previously	
shown.15,16	We	could	also	see	transmigrated	melanoma	cells	on	the	
















integration	of	cancer	cells	 into	 the	brain	endothelial	 layer	was	not	
observed	for	melanoma	cells.	Moreover,	the	endothelial	monolayer	




membrane	 protrusion	 formation,	 tumour	 cell	 incorporation	 and	
junctional	disassembly.	Recently,	CECs	were	suggested	to	activate	
cofilin	in	response	to	extracellular	vesicles	secreted	by	breast	cancer	





























migration of tumour cells
Besides	 disruption	 of	 TJs,	 melanoma	 cells	 must	 open	 the	 AJs	 of	
CECs	during	their	paracellular	migration	from	the	apical	to	the	baso-
lateral	 side	 of	 the	 endothelium.	 N-	cadherin-	mediated	 interaction	
was	 shown	 to	be	 involved	 in	 this	process	 in	non-	brain	endothelial	
cells.17	 Therefore,	 we	 investigated	 involvement	 of	 N-	cadherin	 in	
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the	migration	of	melanoma	and	breast	 cancer	 cells	 through	CECs.	
When	melanoma	cells	were	seeded	upon	a	confluent	monolayer	of	
CECs,	 tumour	cells	 tended	 to	 rapidly	 intercalate	among	CECs.	We	
observed	the	appearance	of	N-	cadherin	in	the	melanoma-	melanoma	
and	 melanoma-	endothelial	 contact	 regions	 (Figure	5A).	 However,	





Therefore,	 as	 a	 next	 step	 we	 investigated	 the	 ability	 of	 
N-	cadherin-	negative	 breast	 cancer	 cells	 to	 give	 brain	 metastases	
in	 vivo.	As	 a	unique	 feature	of	brain	metastasis	 formation,	 tumour	










negative	 throughout	 the	 metastatic	 process.	 N-	cadherin	 was	 only	
















travasation	of	cancer	cells	 into	 the	CNS	 is	 largely	uncharacterized	
and	might	be	both	offensive	and	defensive	at	 the	 same	 time	with	




Our	 in	 vitro	 and	 in	 vivo	 results	 indicate	 that	CECs	play	 an	 ac-











for	 platelet-	derived	 microparticles,24	 pathogenic	 Escherichia 
coli bacteria 25	and	nanoparticles	26	through	the	BBB.	However,	
molecular	mechanisms	of	 tumour-	endothelial	 interactions	still	
need	 to	 be	 studied.	 Cofilin	 activation	 indicates	 involvement	
of	 the	 actin-	myosin	 network.	 Nevertheless,	 cofilin-	induced	
modulation	 of	 actin	 dynamics	 in	 CECs	 has	 been	 shown	 to	
promote	 transendothelial	 migration	 of	 breast	 cancer	 cells	
and	 formation	of	brain	metastases	 in	vivo.21	According	 to	 the	
study	 of	 Tominaga	 et al,21	 breast	 cancer-	derived	 extracellu-
lar	 vesicles	 containing	miR-	181c	 promote	 destruction	 of	 BBB	
TJs	 through	 reorganization	 of	 actin,	 via	 down-	regulation	 of	
3-	phosphoinositide-	dependent	 protein	 kinase-	1	 (PDPK1)	 and	
down-	regulation	 of	 phospho-	cofilin	 (i.e.	 activation	 of	 cofilin).	
Therefore,	 remodelling	 of	 the	 endothelial	 cytoskeleton	might	
be	 actively	 involved	 in	 regulating	 interactions	 of	 cancer	 cells	
with	 the	 cerebral	 endothelium.	 Nevertheless,	 the	 exact	 role	



















cells	 to	 proceed	 further	 to	 the	 paracellular	 transmigration.	We	
use	 the	 term	 “incorporation”	 for	 describing	 tumour	 cells—inde-
pendently	 whether	 intact	 or	 not—completely	 covered	 by	 en-
dothelial	 cells.	 This	 phenomenon	 was	 mostly	 seen	 with	 breast	
cancer	cells,	most	 likely	 linked	to	the	transcellular	type	of	tran-
sendothelial	migration.
To	 our	 best	 knowledge,	we	 are	 the	 first	 to	 show	 direct	 evi-
dence	of	transcellular	migration	of	tumour	cells	through	the	BBB.	
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The	transcellular	route	of	migration	has	initially	been	recognized	
for	 leukocytes,28	 especially	 in	 the	 brain	 microvasculature.29,30 
As	for	tumour	cells,	the	transcellular	route	of	migration	has	only	
been	described	 in	 the	 diapedesis	 of	 breast	 cancer	 cells	 through	
an	 in	vitro	vascular	network	31	or	 through	human	umbilical	cord	
endothelial	cells	 (HUVECs).32	During	this	process	an	actomyosin	
transcellular	 circumferential	 invasion	 array	 is	 formed,	 regulated	
by	myosin	light	chain	kinase	(MLCK)	and	myosin	II	regulatory	light	
chain	 (RLC)	 phosphorylation.	 Further	 studies	 are	 needed	 to	 un-
derstand	which	signalling	pathways	are	involved	in	the	regulation	
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During	paracellular	migration,	melanoma	cells	disrupt	the	
TJs	of	CECs.15	Not	only	TJs,	but	AJs	are	also	 involved	 in	this	
process.	Melanoma	 cells	 may	 adhere	 in	 clusters	 to	 cerebral	
endothelial	cells,	and	attach	to	each	other	and	to	endothelial	








is	mainly	 involved	 in	melanoma-	endothelial	 interactions,	but	
is	 dispensable	 in	 the	 transendothelial	 migration	 of	 breast	
cancer	 cells	 both	 in	 vitro	 and	 in	 vivo.	 A	 few	 days	 after	 the	
injection	 of	 breast	 cancer	 cells	 into	 the	 mice,	 we	 observed	
up-	regulation	of	N-	cadherin	 in	brain	microvascular	endothe-
lial	cells;	however,	4T1	breast	cancer	cells	did	not	up-	regulate	
N-	cadherin	 expression	 either	 before,	 or	 during	 or	 after	 ex-
travasation.	This	indicates	an	N-	cadherin-	independent	trans-




Taken	 together,	 our	 results	 indicate	 that—through	 cytoskele-
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is	directly	 involved	 in	extravasation	of	 tumour	cells	 into	 the	brain.	
We	also	show	that	melanoma	cells	primarily	utilize	the	paracellular	
route	 of	 transendothelial	 migration,	 while	 breast	 cancer	 cells	 are	
able	 to	 transcellularly	 migrate	 through	 the	 brain	 endothelial	 cell	
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